{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:58:16Z","timestamp":1792519096923,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007941","name":"Addis Ababa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009698","name":"Hawassa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.athplu.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:00:29Z","timestamp":1754496029000},"page":"48-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The association between dolutegravir based first-line antiretroviral regimens and dyslipidemia among adults living with HIV on follow-up at health facilities in Hawassa city administration, Sidama region: a cross-sectional study"],"prefix":"10.1016","volume":"61","author":[{"given":"Agete Tadewos","family":"Hirigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemayehu","family":"Abera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Yilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Astatkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelalem","family":"Debebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib1","doi-asserted-by":"crossref","DOI":"10.5334\/gh.403","article-title":"Cardiovascular diseases in Sub-Saharan Africa compared to high-income countries: an epidemiological perspective","volume":"15","author":"Yuyun","year":"2020","journal-title":"Global heart"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s42399-023-01605-x","article-title":"Cardiovascular health priorities in Sub-Saharan Africa","volume":"5","author":"Obonyo","year":"2023","journal-title":"SN Comprehensive Clinical Medicine"},{"key":"10.1016\/j.athplu.2025.08.001_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-020-01828-z","article-title":"The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies","volume":"21","author":"Angaw","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"9738","key":"10.1016\/j.athplu.2025.08.001_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(10)60932-4","article-title":"Death rates in HIV-Positive antiretroviral-naive patients with CD4 count greater than 350 cells per \u03bcL in Europe and North America: a pooled cohort observational study","volume":"376","author":"Lodwick","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.athplu.2025.08.001_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2295435","article-title":"Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART; a comparative cross-sectional study","volume":"55","author":"Jemal","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.athplu.2025.08.001_bib6","series-title":"Time to recognize HIV infection as a major cardiovascular risk factor","first-page":"1113","author":"Hsue","year":"2018"},{"issue":"6","key":"10.1016\/j.athplu.2025.08.001_bib7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/jac\/dkv494","article-title":"Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-Infected patients","volume":"71","author":"Calza","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.athplu.2025.08.001_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QAD.0b013e328341f925","article-title":"Impact of NRTIs on lipid levels among a large HIV-Infected cohort initiating antiretroviral therapy in clinical care","volume":"25","author":"Crane","year":"2011","journal-title":"AIDS (London, England)"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-7-380","article-title":"Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at burayu health center, addis ababa, Ethiopia: a cross-sectional comparative study","volume":"7","author":"Abebe","year":"2014","journal-title":"BMC Res Notes"},{"issue":"3","key":"10.1016\/j.athplu.2025.08.001_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151911","article-title":"Anti-retroviral therapy increases the prevalence of dyslipidemia in South African HIV-Infected patients","volume":"11","author":"Dave","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12879-023-08892-8","article-title":"Dyslipidemia among adult people living with HIV on dolutegravir\u2013based antiretroviral therapy at a private tertiary hospital in kampala, Uganda: burden and determinants","volume":"24","author":"Kigongo","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.athplu.2025.08.001_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247004","article-title":"Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: an opportunity to consider non-communicable diseases in resource-limited settings","volume":"16","author":"Hamooya","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.athplu.2025.08.001_bib13","article-title":"The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-Infected patients: comparison between NRTI\/NNRTI and NRTI\/INSTI","volume":"11","author":"Liu","year":"2023","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/QAD.0000000000002421","article-title":"Weight gain in people living with HIV switched to dual therapy: changes in body fat mass","volume":"34","author":"Vizcarra","year":"2020","journal-title":"Aids"},{"issue":"6","key":"10.1016\/j.athplu.2025.08.001_bib15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.athplu.2025.08.001_bib16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/INF.0000000000001963","article-title":"Longitudinal changes in body composition by dual energy X-ray absorptiometry among perinatally HIV-Infected and HIV-Uninfected youth: increased risk of adiposity among HIV-Infected female youth","volume":"37","author":"Sharma","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.athplu.2025.08.001_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26123","article-title":"Incidence of cardiometabolic outcomes among people living with HIV\u20101 initiated on integrase strand transfer inhibitor versus non\u2010integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States","volume":"26","author":"Rebeiro","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.athplu.2025.08.001_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/IDR.S203813","article-title":"Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir\/abacavir\/lamivudine: data from the SCOLTA project","author":"Bagella","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"Supplement 2","key":"10.1016\/j.athplu.2025.08.001_bib19","first-page":"869","article-title":"Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents","volume":"35","author":"Byonanebye","year":"2021","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.athplu.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40261-014-0266-2","article-title":"Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks","volume":"35","author":"Quercia","year":"2015","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.athplu.2025.08.001_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102255","article-title":"The burden of non-communicable diseases among people living with HIV in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"65","author":"Moyo-Chilufya","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.athplu.2025.08.001_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70054","article-title":"Hyperglycaemia and its risk factors among adults living with HIV on Follow-Up at the hawassa city administration, southern Ethiopia: a cross-sectional study","volume":"8","author":"Hirigo","year":"2025","journal-title":"Endocrinology, diabetes & metabolism"},{"key":"10.1016\/j.athplu.2025.08.001_bib23","series-title":"Chronic diseases and health promotion: stepwise approach to surveillance (STEPS)","year":"2010"},{"issue":"25","key":"10.1016\/j.athplu.2025.08.001_bib24","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2025.08.001_bib25","series-title":"Clinical practice guidelines for hypertension 2003","first-page":"940","author":"Mart\u00ednez","year":"2003"},{"key":"10.1016\/j.athplu.2025.08.001_bib26","first-page":"8","article-title":"Waist circumference and waist-hip ratio","volume":"2008","year":"2008"},{"key":"10.1016\/j.athplu.2025.08.001_bib27","unstructured":"Omron. OMRON: HBF-514 full body sensor body composition monitor and ScalFull body sensor body composition monitor and scale, manual. Omron Healthcare, Inc. www.omronhealthcare.com2008."},{"issue":"4","key":"10.1016\/j.athplu.2025.08.001_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1123\/ijsnem.2018-0283","article-title":"Reliability and validity of commercially available low-cost bioelectrical impedance analysis","volume":"29","author":"Vasold","year":"2019","journal-title":"Int J Sport Nutr Exerc Metabol"},{"key":"10.1016\/j.athplu.2025.08.001_bib29","series-title":"StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing","article-title":"BMI Classification Percentile and Cut Off Points. [Updated 2023 Jun 26]","author":"Weir","year":"2025"},{"issue":"8","key":"10.1016\/j.athplu.2025.08.001_bib30","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-Country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"10","key":"10.1016\/j.athplu.2025.08.001_bib32","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","article-title":"Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide","volume":"28","author":"Fossati","year":"1982","journal-title":"Clin Chem"},{"issue":"12","key":"10.1016\/j.athplu.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/clinchem\/24.12.2161","article-title":"The 4-hydroxybenzoate\/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol","volume":"24","author":"Meiattini","year":"1978","journal-title":"Clin Chem"},{"key":"10.1016\/j.athplu.2025.08.001_bib34","author":"Sonagra","year":"2025"},{"issue":"9","key":"10.1016\/j.athplu.2025.08.001_bib35","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/clinchem\/47.9.1579","article-title":"Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays","volume":"47","author":"Warnick","year":"2001","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.athplu.2025.08.001_bib36","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/clinchem\/42.5.780","article-title":"Direct measurement of LDL cholesterol","volume":"42","author":"Levinson","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.athplu.2025.08.001_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/HIV.S418729","article-title":"Dyslipidemia and nutritional status of HIV-infected children and adolescents on antiretroviral treatment at the comprehensive chronic care and training center of jimma medical center","author":"Ambisa Lamesa","year":"2023","journal-title":"HIV\/AIDS-Research and Palliative Care"},{"issue":"6","key":"10.1016\/j.athplu.2025.08.001_bib38","doi-asserted-by":"crossref","first-page":"H1221","DOI":"10.1152\/ajpheart.00445.2020","article-title":"HIV-Related cardiovascular disease: any role for high-density lipoproteins?","volume":"319","author":"Hudson","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.athplu.2025.08.001_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/HIV.S252391","article-title":"Dyslipidemia and associated factors among adult patients on antiretroviral therapy in armed force comprehensive and specialized hospital, addis Ababa, Ethiopia","author":"Kemal","year":"2020","journal-title":"HIV\/AIDS-Research and Palliative Care"},{"issue":"2","key":"10.1016\/j.athplu.2025.08.001_bib40","first-page":"164","article-title":"Lipid profile in HIV-Infected patients using first-line antiretroviral drugs","volume":"15","author":"Ombeni","year":"2016","journal-title":"J Int Assoc Phys AIDS Care"},{"issue":"4","key":"10.1016\/j.athplu.2025.08.001_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250328","article-title":"Prevalence of dyslipidaemia among HIV-Infected patients receiving combination antiretroviral therapy in north shewa, Ethiopia","volume":"16","author":"Fiseha","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12879-023-08910-9","article-title":"Dyslipidemia among HIV-Infected patients in Ethiopia: a systematic review and meta-analysis","volume":"24","author":"Mohammed","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.athplu.2025.08.001_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298525","article-title":"Dyslipidemia among adult HIV patients on antiretroviral therapy and its association with age and body mass index in Ethiopia: a systematic review and meta-analysis","volume":"19","author":"Belete","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.athplu.2025.08.001_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/HIV.S430310","article-title":"Serum lipid profiles, blood glucose, and high-sensitivity C-Reactive protein levels among people living with HIV taking dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy at jimma university medical center, southwest Ethiopia, 2021","author":"Waritu","year":"2024","journal-title":"HIV\/AIDS-Research and Palliative Care"},{"key":"10.1016\/j.athplu.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/DHPS.S395037","article-title":"Prevalence and factors associated with dyslipidemia among people living with HIV\/AIDS on Follow-Up care at a tertiary care hospital in Ethiopia: a cross-sectional study","author":"Assefa","year":"2023","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.athplu.2025.08.001_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.obmed.2020.100217","article-title":"Dyslipidemia in HIV\/AIDS infected patients on follow up at referral hospitals of northwest Ethiopia: a laboratory-based cross-sectional study","volume":"18","author":"Gebrie","year":"2020","journal-title":"Obesity Medicine"},{"issue":"4","key":"10.1016\/j.athplu.2025.08.001_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25901","article-title":"Prevalence of cardiovascular risk factors by HIV status in a population\u2010based cohort in south central Uganda: a cross\u2010sectional survey","volume":"25","author":"Enriquez","year":"2022","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"10.1016\/j.athplu.2025.08.001_bib48","first-page":"159","article-title":"Features of metabolic syndrome and its associated factors during highly active antiretroviral therapy in ouagadougou (burkina faso)","volume":"15","author":"Guira","year":"2016","journal-title":"J Int Assoc Phys AIDS Care"},{"issue":"5","key":"10.1016\/j.athplu.2025.08.001_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126166","article-title":"Prevalence of dyslipidaemia and associated risk factors in a rural population in south-western Uganda: a community based survey","volume":"10","author":"Asiki","year":"2015","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.athplu.2025.08.001_bib50","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"48","key":"10.1016\/j.athplu.2025.08.001_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002201","article-title":"Prevalence of dyslipidemia among antiretroviral-naive HIV-Infected individuals in China","volume":"94","author":"Shen","year":"2015","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.athplu.2025.08.001_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270838","article-title":"Dyslipidemia and associated risk factors among HIV\/AIDS patients on HAART in asmara, Eritrea","volume":"17","author":"Achila","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.athplu.2025.08.001_bib53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/INF.0000000000003066","article-title":"Body fat distribution and metabolic changes in a cohort of adolescents living with HIV switched to an antiretroviral regimen containing dolutegravir","volume":"40","author":"Giacomet","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.athplu.2025.08.001_bib54","series-title":"Prevalence of cardiometabolic disease risk factors in people with HIV initiating antiretroviral therapy at a high-volume HIV clinic in kampala, Uganda. Open forum infectious diseases","year":"2023"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12872-019-1228-7","article-title":"The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women's health in the lund area (WHILA): a 17-year follow-up cohort study","volume":"19","author":"Calling","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"10.1016\/j.athplu.2025.08.001_bib56","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41440-019-0251-5","article-title":"Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol\/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population","volume":"42","author":"Wen","year":"2019","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s40001-024-01769-9","article-title":"A non-linear connection between the total cholesterol to high-density lipoprotein cholesterol ratio and stroke risk: a retrospective cohort study from the China health and retirement longitudinal study","volume":"29","author":"Xiao","year":"2024","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210629","article-title":"Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: a prospective cohort study","volume":"14","author":"Amberbir","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4620951","article-title":"Weight and lipid levels in people living with HIV and initiating a dolutegravir\u2010based regimen in a resource limited setting: a prospective study","volume":"2024","author":"Chakanetsa","year":"2024","journal-title":"AIDS Research and Treatment"},{"issue":"10","key":"10.1016\/j.athplu.2025.08.001_bib60","article-title":"The impact of contemporary antiretroviral drugs on atherosclerosis and its complications in people living with HIV: a systematic review","volume":"15","author":"Vemulapalli","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.athplu.2025.08.001_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.33393\/dti.2023.2529","article-title":"Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir","volume":"17","author":"Khemla","year":"2023","journal-title":"Drug Target Insights"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib62","article-title":"Incidence of hyperlipidemia among adults initiating antiretroviral therapy in the HIV outpatient study (HOPS), USA, 2007\u20132021","volume":"2023","author":"Li","year":"2023","journal-title":"AIDS Research and Treatment"},{"issue":"11","key":"10.1016\/j.athplu.2025.08.001_bib63","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.3390\/jcm12113644","article-title":"Weight and metabolic outcomes in na\u00efve HIV patients treated with integrase inhibitor-based antiretroviral therapy: a systematic review and meta-analysis","volume":"12","author":"Valenzuela-Rodriguez","year":"2023","journal-title":"J Clin Med"},{"issue":"47","key":"10.1016\/j.athplu.2025.08.001_bib64","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022998","article-title":"The correlation between neck circumference and risk factors in patients with hypertension: what matters","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.athplu.2025.08.001_bib65","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/eurjcn\/zvaa018","article-title":"Association between neck circumference and lipid profile: a systematic review and meta-analysis of observational studies","volume":"20","author":"Shokri-Mashhadi","year":"2021","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"1","key":"10.1016\/j.athplu.2025.08.001_bib66","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/dmrr.2369","article-title":"Neck circumference is correlated with triglycerides and inversely related with HDL cholesterol beyond BMI and waist circumference","volume":"29","author":"Vallianou","year":"2013","journal-title":"Diabetes\/metabolism research and reviews"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089525000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089525000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:02:28Z","timestamp":1758621748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089525000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":65,"alternative-id":["S2667089525000203"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2025.08.001","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between dolutegravir based first-line antiretroviral regimens and dyslipidemia among adults living with HIV on follow-up at health facilities in Hawassa city administration, Sidama region: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}